1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
4MOST: Project overview and information for the First Call for Proposals
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo (R) (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess (R)/Comtan (R) (Entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment
(
- Contribution to journal › Article
- 2000
-
Mark
Macromolecular crowding and its conequences
(
- Contribution to journal › Article
-
Mark
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
(
- Contribution to journal › Article
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
(
- Contribution to journal › Article
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
- 1994
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1992
-
Mark
Core assessment program for intracerebral transplantations (CAPIT)
(
- Contribution to journal › Article